Are potassium channel blockers beneficial?
Unlike some of the other heart rhythm drugs, class III antiarrhythmics do not increase the risk of dying early in men or women with heart disease.21-23 A version of sotalol increased the risk of dying from heart rhythm disturbances when used to prevent arrhythmias in heart attack patients.24 This risk was higher for women than men.25 That formulation of sotalol is no longer used. The current version of sotalol (Betapace) does not increase the risk of dying from heart rhythm problems when given to people with heart disease.26 Class III antiarrhythmic medications are not used to prevent heart rhythm problems because it is not clear whether they are beneficial in that situation. These medications may be used to treat arrhythmias in men and women with heart disease who are taking beta blockers but continue to experience heart rhythm problems, including atrial fibrillation. Atrial fibrillation is a rapid, disordered contraction of the heart muscles whereby the heart flutters in an uncontrolled manner.
Prescribed Class III Antiarrhythmics
|
Class III Antiarrhythmics – Potassium Channel Blockers |
|||
|
Generic: |
Amiodarone |
Dofetilide |
Sotalol |
|
Brand: |
Cordarone |
Tikosyn |
Betapace |
|
Administration: |
Oral, intravenous |
||
|
What is it used for: |
|
||
|
You should not take this medication: |
|
||
|
Common side effects: |
|
||
|
Pregnancy/nursing: |
|
||
Choice of Medication
Amiodarone (Pacerone or Cordarone) is better than sotalol for correcting heart rhythm disturbances;27 however, it has a higher risk of very serious side effects. In two major studies, many heart attack patients prescribed amiodarone stopped taking it because of side effects, including serious lung and liver problems.21, 22 In one study of elderly heart attack patients with atrial fibrillation, women treated with amiodarone had a higher risk of developing a slow irregular heartbeat (bradyarrhythmia) requiring permanent pacemaker than men taking amiodarone.28 Because of these risks, sotalol is generally the first choice.29 Dofetilide (Tikosyn) is newer and has not been studied as much as the other class III antiarrhythmics. Both amiodarone and dofetilide have been shown to benefit men and women with heart failure.30, 31 Sotalol and dofetilide may trigger a potentially dangerous rapid heart beat (torsade de pointes), particularly in women.
Amiodarone or sotalol may also be given to people with ICDs to reduce the number of shocks.


